Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 17, 2016
Comparison of in vitro antileukemic activity of obatoclax and ABT-737Małgorzata Opydo-Chanek, Lidia Mazur
Folia Biologica|February 25, 2003
Phosphatidylserine externalization during bone marrow cell death after treatment of mice with WR-2721 and gamma-raysLidia Mazur, Michał Bochenek, Anna Augustynek
Klinika Oczna|October 14, 2003
[Side effects during treatment with Solu-Medrol for optic neuritis in the course of MS]Lidia Mazur-Chłodek, Aniela Kaliciak-Kempińska
Indian Journal of Experimental Biology|November 16, 2013
In vitro cytotoxicity testing of new generation oxazaphosphorines against human histiocytic lymphoma cellsMałgorzata Opydo-Chanek, Lidia Mazur, Marta Stojak
Anti-Cancer Drugs|March 24, 2011
Glufosfamide as a new oxazaphosphorine anticancer agentLidia Mazur, Małgorzata Opydo-Chanek, Marta Stojak
Folia Biologica|June 18, 2013
In vitro effects of new generation oxazaphosphorines on human promyelocytic leukemia cellsLidia Mazur, Małgorzata Opydo-Chanek, Marta Stojak, et al.
Indian Journal of Experimental Biology|July 13, 2017
In vitro cytotoxic activity evaluation of phenytoin derivatives against human leukemia cellsKatarzyna Śladowska, Jadwiga Handzlik, Katarzyna Kieć-Kononowicz, et al.
Anticancer Research|July 4, 2012
Mafosfamide as a new anticancer agent: preclinical investigations and clinical trialsLidia Mazur, Malgorzata Opydo-Chanek, Marta Stojak, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 4, 2017
Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cellsMałgorzata Opydo-Chanek, Agnieszka Rak, Agnieszka Cierniak, et al.
Pageof 3